Inflammatory Mechanisms Underlie Lysosome Failure in the Aging Brain
炎症机制是衰老大脑中溶酶体衰竭的基础
基本信息
- 批准号:10406349
- 负责人:
- 金额:$ 35.99万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2018
- 资助国家:美国
- 起止时间:2018-09-15 至 2024-04-30
- 项目状态:已结题
- 来源:
- 关键词:AcidsAddressAdultAgeAgingAlkalinizationAlzheimer&aposs DiseaseAlzheimer&aposs disease riskAmericanAnimalsAstrocytesAutophagolysosomeAutophagosomeBrainCathepsinsCell physiologyCellsCellular StructuresCenters for Disease Control and Prevention (U.S.)ChemicalsChronicConfocal MicroscopyDataDementiaDevelopmentDiseaseElderlyEnzymesEtiologyEventFailureFiberGenesGlial Fibrillary Acidic ProteinGrantHealthcareHumanImageImmuneImpairmentInduced pluripotent stem cell derived neuronsInflammationInflammatoryInjuryInterleukin-6InterventionLaboratoriesLeadLinkLiteratureLysosomesMediatingModificationMorphologyMusNADPH OxidaseNatural ImmunityNerve DegenerationNeurodegenerative DisordersNeuronal InjuryNeuronsOrganellesOrganismOxidation-ReductionParkinson DiseasePathologic ProcessesPeptide HydrolasesPharmacologyProcessProteinsProteolysisPublishingRecyclingRegulationReportingResolutionRiskRisk FactorsRoleSTAT3 geneSchemeSignal TransductionSiteSynapsesTechniquesTestingage relatedage related neurodegenerationagedaging brainalkalinitybasebrain healthcell injurycytokineeffective interventioneffective therapyflygenetic approachgenome wide association studyhuman old age (65+)improvedin vivoinduced pluripotent stem cellinhibitorinsightlysosomal proteinsmouse modelnervous system disordernormal agingnovelrisk variantvacuolar H+-ATPase
项目摘要
According to the Centers for Disease Control (CDC), 5 million Americans are living with Alzheimer's disease
(AD), and another 2 million with Parkinson's disease (PD) and other late-onset neurodegenerative conditions
(LO-NDs), yet to date, disease-modifying treatments for these diseases have remained elusive. While aging is
the single greatest risk factor for LO-NDs, genome wide association studies (GWAS) have identified genes
involved in regulation of lysosomes (vesicular organelles responsible for degrading and recycling damaged
cellular material), and activation of inflammation and innate immunity, as LO-ND risk genes. However, to date, it
is unclear how these two processes may interact in aging brain to promote the development of LO-NDs. Our
data suggests that lysosomes may progressively fail during normal aging – even in the absence of a specific
disease process or gene – and further suggest that low-grade induction of the innate immune enzyme, NADPH
oxidase (Nox), by IL-6, may specifically result in lysosome failure in the aging brain. Exciting new data, below,
shows that lysosomal failure in aging brain can be rescued by inhibition of Nox. Therefore based on recent
literature, and our published and new observations, we propose that age-related lysosome failure is due
to IL-6-mediated activation of NADPH oxidase, and propose mechanistic studies to test each component
of this hypothesis. The premise behind this application, that inflammation in aging brain causes progressive
failure of lysosomes, is supported by existing literature, our published studies, and new preliminary data, but has
not been systematically studied. Aim 1 will test the hypothesis that lysosome failure during aging is due to
inflammatory activation of Nox, and the corollary that Nox induction is mediated by Il-6 and STAT3
signaling. Our data showing that lysosomal function can be rescued by a Nox inhibitor in aging animals supports
the first step in this hypothesis, and is to our knowledge the first to show that Nox inhibition can improve brain
lysosome function. Unique mouse models, including PV-tdTomato, IL-6-/- and inducible neuronal Stat3-/- mice
with high-resolution confocal microscopy will be used. Aim 2 will determine mechanistically how
inflammation produces lysosome failure and impaired degradation of cargo in aging brain. Induced
pluripotent stem cell (iPSC)-derived human neurons (iPSC-huNs), and aged mice treated with Nox-modifying
agents will determine mechanisms impairing lysosome function. Aim 3 tests the hypotheses that extruded
lysosomal cargo contains active proteases which then damage nearby cells including neurons, and that
extruded lysosomal material (cargo) is pro-inflammatory. Imaging of cathepsin activity, neuronal injury and
markers of microglial and astrocyte activation will be employed. IMPACT: Age-related diseases of the nervous
system are an ever-increasing health care issue, but no disease-modifying treatments have emerged for these
diseases. This proposal will advance our understanding of how inflammation impairs the ability of lysosomes to
clear and recycle damaged cellular material to provide new treatment targets for neurodegenerative disorders.
根据疾病控制中心(CDC)的数据,有500万美国人患有阿尔茨海默病
(AD)另有200万人患有帕金森病(PD)和其他迟发性神经退行性疾病
尽管这些疾病是LO-ND,但迄今为止,用于这些疾病的疾病修饰治疗仍然难以捉摸。虽然衰老是
作为LO-ND的最大风险因素,全基因组关联研究(GWAS)已经确定了
参与调节溶酶体(负责降解和回收受损的泡状细胞器
细胞物质),以及炎症和先天免疫的激活,作为LO-ND风险基因。然而,迄今为止,
目前尚不清楚这两个过程如何在衰老的大脑中相互作用,以促进LO-ND的发展。我们
数据表明,在正常衰老过程中,溶酶体可能会逐渐衰竭,即使在缺乏特定的
疾病过程或基因-并进一步表明,低级别诱导的先天免疫酶,NADPH
IL-6诱导的Nox可能特异性地导致衰老大脑中的溶酶体衰竭。令人兴奋的新数据,下面,
显示老化脑中的溶酶体衰竭可以通过抑制Nox来挽救。根据最近
结合文献,以及我们发表的和新的观察,我们提出年龄相关的溶酶体衰竭是由于
IL-6介导的NADPH氧化酶的激活,并提出机制研究,以测试每个组件
这一假设。这个应用背后的前提是,老化大脑中的炎症会导致渐进性的
现有文献、我们已发表的研究和新的初步数据都支持溶酶体的失败,但
没有被系统地研究过。目的1将检验老化过程中溶酶体失效是由于
Nox的炎性激活,以及Nox诱导由IL-6和STAT 3介导的推论
信号我们的数据显示,在衰老动物中,溶酶体功能可以通过Nox抑制剂来拯救,这支持了
这是这一假设的第一步,据我们所知,这是第一个表明Nox抑制可以改善大脑
溶酶体功能独特的小鼠模型,包括PV-tdTomato、IL-6-/-和可诱导神经元Stat 3-/-小鼠
将使用高分辨率共焦显微镜。目标2将机械地确定如何
炎症在老化的大脑中产生溶酶体失效和受损的货物降解。诱导
多能干细胞(iPSC)衍生的人神经元(iPSC-huN)和用Nox修饰的人神经元处理的老年小鼠。
试剂将确定损害溶酶体功能的机制。目标3测试了挤出的假设,
溶酶体货物含有活性蛋白酶,其然后损伤附近的细胞,包括神经元,并且
挤出的溶酶体物质(货物)是促炎性的。组织蛋白酶活性、神经元损伤和
将使用小胶质细胞和星形胶质细胞活化的标记物。影响:与神经系统相关的疾病
系统是一个不断增长的卫生保健问题,但还没有出现针对这些系统的疾病改善治疗方法
疾病这一提议将促进我们对炎症如何损害溶酶体的能力的理解,
清除和回收受损的细胞物质,为神经退行性疾病提供新的治疗靶点。
项目成果
期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Neutrophil-mediated oxidative stress and albumin structural damage predict COVID-19-associated mortality.
- DOI:10.7554/elife.69417
- 发表时间:2021-11-25
- 期刊:
- 影响因子:7.7
- 作者:Badawy MA;Yasseen BA;El-Messiery RM;Abdel-Rahman EA;Elkhodiry AA;Kamel AG;El-Sayed H;Shedra AM;Hamdy R;Zidan M;Al-Raawi D;Hammad M;Elsharkawy N;El Ansary M;Al-Halfawy A;Elhadad A;Hatem A;Abouelnaga S;Dugan LL;Ali SS
- 通讯作者:Ali SS
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Laura L Dugan其他文献
Mitochondrial Uncoupling Proteins in the Central Nervous System Recommended Citation
中枢神经系统中的线粒体解偶联蛋白推荐引文
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
Jeong Sook;Kim;Laura L Dugan;Dugan;Laura L - 通讯作者:
Laura L
Laura L Dugan的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Laura L Dugan', 18)}}的其他基金
Novel treatments for neuropsychiatric symptoms in Alzheimers Disease (AD): targeting inflammatory injury using three translational anti-inflammatory strategies in a new AD model.
阿尔茨海默病 (AD) 神经精神症状的新疗法:在新的 AD 模型中使用三种转化抗炎策略来靶向炎症损伤。
- 批准号:
10514598 - 财政年份:2019
- 资助金额:
$ 35.99万 - 项目类别:
Novel treatments for neuropsychiatric symptoms in Alzheimers Disease (AD): targeting inflammatory injury using three translational anti-inflammatory strategies in a new AD model.
阿尔茨海默病 (AD) 神经精神症状的新疗法:在新的 AD 模型中使用三种转化抗炎策略来靶向炎症损伤。
- 批准号:
9665155 - 财政年份:2019
- 资助金额:
$ 35.99万 - 项目类别:
Novel treatments for neuropsychiatric symptoms in Alzheimers Disease (AD): targeting inflammatory injury using three translational anti-inflammatory strategies in a new AD model.
阿尔茨海默病 (AD) 神经精神症状的新疗法:在新的 AD 模型中使用三种转化抗炎策略来靶向炎症损伤。
- 批准号:
10043824 - 财政年份:2019
- 资助金额:
$ 35.99万 - 项目类别:
Novel treatments for neuropsychiatric symptoms in Alzheimers Disease (AD): targeting inflammatory injury using three translational anti-inflammatory strategies in a new AD model.
阿尔茨海默病 (AD) 神经精神症状的新疗法:在新的 AD 模型中使用三种转化抗炎策略来靶向炎症损伤。
- 批准号:
10292955 - 财政年份:2019
- 资助金额:
$ 35.99万 - 项目类别:
Inflammatory Mechanisms Underlie Lysosome Failure in the Aging Brain
炎症机制是衰老大脑中溶酶体衰竭的基础
- 批准号:
10159817 - 财政年份:2018
- 资助金额:
$ 35.99万 - 项目类别:
Inflammatory Mechanisms Underlie Lysosome Failure in the Aging Brain
炎症机制是衰老大脑中溶酶体衰竭的基础
- 批准号:
9923516 - 财政年份:2018
- 资助金额:
$ 35.99万 - 项目类别:
Systemic Inflammation and Central Nervous System Dysfunction
全身炎症和中枢神经系统功能障碍
- 批准号:
9293672 - 财政年份:2010
- 资助金额:
$ 35.99万 - 项目类别:
Systemic Inflammation and Central Nervous System Dysfunction
全身炎症和中枢神经系统功能障碍
- 批准号:
8113936 - 财政年份:2010
- 资助金额:
$ 35.99万 - 项目类别:
Systemic Inflammation and Central Nervous System Dysfunction
全身炎症和中枢神经系统功能障碍
- 批准号:
8292022 - 财政年份:2010
- 资助金额:
$ 35.99万 - 项目类别:
Systemic Inflammation and Central Nervous System Dysfunction
全身炎症和中枢神经系统功能障碍
- 批准号:
8705765 - 财政年份:2010
- 资助金额:
$ 35.99万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 35.99万 - 项目类别:
Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 35.99万 - 项目类别:
Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 35.99万 - 项目类别:
Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 35.99万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 35.99万 - 项目类别:
Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 35.99万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 35.99万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 35.99万 - 项目类别:
EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 35.99万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 35.99万 - 项目类别:
Research Grant